Eukaryotic Initiation Factor 2α - a Downstream Effector of Mammalian Target of Rapamycin - Modulates DNA Repair and Cancer Response to Treatment

In an effort to circumvent resistance to rapamycin – an mTOR inhibitor - we searched for novel rapamycin-downstream-targets that may be key players in the response of cancer cells to therapy. We found that rapamycin, at nM concentrations, increased phosphorylation of eukaryotic initiation factor (eI...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuval-Kochen, Liron, Paglin, Shoshana, Keshet, Gilmor, Lerenthal, Yaniv, Nakar, Charles, Golani, Tamar, Toren, Amos, Yahalom, Joachim, Pfeffer, Raphael, Lawrence, Yaacov
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808413/
https://www.ncbi.nlm.nih.gov/pubmed/24204783
http://dx.doi.org/10.1371/journal.pone.0077260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808413/
https://www.ncbi.nlm.nih.gov/pubmed/24204783
http://dx.doi.org/10.1371/journal.pone.0077260

Ejemplares similares